Author/Authors :
herraez, elisa university of salamanca - experimental hepatology and drug targeting (hevefarm), ibsal, Salamanca, Spain , herraez, elisa carlos iii national health institute - national institute for the study of liver and gastrointestinal diseases (ciberehd), Madrid, Spain , romero, marta r. university of salamanca - experimental hepatology and drug targeting (hevefarm), ibsal, Salamanca, Spain , romero, marta r. carlos iii national health institute - national institute for the study of liver and gastrointestinal diseases (ciberehd), Madrid, Spain , macias, rocio i. r. university of salamanca - experimental hepatology and drug targeting (hevefarm), ibsal, Salamanca, Spain , macias, rocio i. r. carlos iii national health institute - national institute for the study of liver and gastrointestinal diseases (ciberehd), Madrid, Spain , monte, maria j. carlos iii national health institute - national institute for the study of liver and gastrointestinal diseases (ciberehd), Madrid, Spain , monte, maria j. university of salamanca - experimental hepatology and drug targeting (hevefarm), ibsal, Salamanca, Spain , marin, jose j. g. university of salamanca - experimental hepatology and drug targeting (hevefarm), ibsal, Salamanca, Spain , marin, jose j. g. carlos iii national health institute - national institute for the study of liver and gastrointestinal diseases (ciberehd), Madrid, Spain
